Correlation Between Genmab AS and Azenta

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Genmab AS and Azenta at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Genmab AS and Azenta into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Genmab AS and Azenta Inc, you can compare the effects of market volatilities on Genmab AS and Azenta and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Genmab AS with a short position of Azenta. Check out your portfolio center. Please also check ongoing floating volatility patterns of Genmab AS and Azenta.

Diversification Opportunities for Genmab AS and Azenta

0.68
  Correlation Coefficient

Poor diversification

The 3 months correlation between Genmab and Azenta is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Genmab AS and Azenta Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Azenta Inc and Genmab AS is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Genmab AS are associated (or correlated) with Azenta. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Azenta Inc has no effect on the direction of Genmab AS i.e., Genmab AS and Azenta go up and down completely randomly.

Pair Corralation between Genmab AS and Azenta

Given the investment horizon of 90 days Genmab AS is expected to under-perform the Azenta. But the stock apears to be less risky and, when comparing its historical volatility, Genmab AS is 1.98 times less risky than Azenta. The stock trades about -0.29 of its potential returns per unit of risk. The Azenta Inc is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest  4,191  in Azenta Inc on August 28, 2024 and sell it today you would earn a total of  367.00  from holding Azenta Inc or generate 8.76% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy95.45%
ValuesDaily Returns

Genmab AS  vs.  Azenta Inc

 Performance 
       Timeline  
Genmab AS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Genmab AS has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Azenta Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Azenta Inc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Azenta is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Genmab AS and Azenta Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Genmab AS and Azenta

The main advantage of trading using opposite Genmab AS and Azenta positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Genmab AS position performs unexpectedly, Azenta can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Azenta will offset losses from the drop in Azenta's long position.
The idea behind Genmab AS and Azenta Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Other Complementary Tools

Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk